In a bid to ensure increased access to medicines, a leading pharmaceutical manufacturer has announced a 50% cut on its major drugs on the market.

The company announced on Wednesday that the move is aimed at improving health care in developing countries like Uganda.

Gsk East African managing director John Musunga says drugs especially anti-malarial, antibiotics like Amoxcyl and dewormers will have their prices immediate cut to 50%.
The move targets deprived house holds who continue to face major challenges in terms of accessibility drugs.

Musunga sides the high cost of drugs as a factor that has led flourishing trade in counterfeit medicines which pose a major health risks to the users.

By Mugisa Isaac Mathias